Table 2.
Hair bundle Density (per 10,000 µm², +/− s.d.) | |||||||
---|---|---|---|---|---|---|---|
Left | t-test vs left ACM | Right | t-test vs CL explantΦ | t-test vs right GT-only explant† | |||
density | +/− | density | +/− | ||||
in situ (n=3) | 89.4 | 4.3 | ** | 87.8 | 2.2 | n.s. | - |
24 hour explantation | Left saccule (control)Φ | Right saccule plus gentamicin | |||||
ACM (4) | 81.4 | 4.4 | - | 73.6† | 3.6 | *** | - |
Incubation with cytoskeletal disruption agents | |||||||
+ colchicine (3) | 63.5 | 3.5 | ** | 56.6 | 3.0 | * | *** |
+ taxol (3) | 80.4 | 6.6 | n.s. | 64.4 | 10.9 | * | n.s. |
+ ML-9 (4) | 44.4 | 19.6 | * | 31.4 | 22.7 | * | ** |
+ Y-27632 (2)‡ | 62.2 | 11.9 | * | 47.9 | 9.9 | * | *** |
+ cytochalasin D (3) | 76.5 | 4.6 | n.s. | 67.1 | 6.7 | * | n.s. |
+ latrunculin A (3) | 84.0 | 3.1 | n.s. | 76.7 | 1.5 | * | n.s. |
not statistically significantly different
p < 0.05
p < 0.01
p < 0.01
contra-lateral
gentamicin
Note, only 2 morphologically intact explants treated with Y-27632 used for statistical analysis and imaging.